DTP-poliovirus vaccine - Daiichi Sankyo/Kitasato Institute/sanofi pasteur

Drug Profile

DTP-poliovirus vaccine - Daiichi Sankyo/Kitasato Institute/sanofi pasteur

Alternative Names: 4-valent combination DTP-poliovirus vaccine - Kitasato Daiichi Sankyo; DD-687; DTP-IPV - Kitasato Daiichi Sankyo; DTP-IPV vaccine; DTP-poliovirus vaccine (Squarekids); DTP-poliovirus vaccine - Daiichi Sankyo Kitasato Institute/Sanofi; DTP-poliovirus vaccine - Kitasato Daiichi Sankyo; IPV-DTP - Daiichi Sankyo; Petussis, diptheria, tetanus, inactivated-poliovirus Salk vaccine - Kitasato Daiichi Sankyo; Quadrivalent DTP-poliovirus vaccine - Kitasato Daiichi Sankyo; Squarekids

Latest Information Update: 30 Aug 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Kitasato Institute; sanofi pasteur - Daiichi Sankyo Company (JV)
  • Developer Daiichi Sankyo Company - Kitasato Institute (JV); sanofi pasteur KK
  • Class Bacterial vaccines; Vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Diphtheria; Pertussis; Poliomyelitis; Tetanus

Most Recent Events

  • 04 Jul 2014 Registered for Diphtheria (prevention) in Japan (SC)
  • 04 Jul 2014 Registered for Pertussis (prevention) in Japan (SC)
  • 04 Jul 2014 Registered for Poliomyelitis (prevention) in Japan (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top